Ponce, S.Brendel, K.Spigel, D. R.Chen, Y.Jove Casulleras, M.Juan-Vidal, O.Rich, P.Hayes, T.Gutierrez Calderon, V.Bernabe Caro, R.Navarro, A.Dowlati, A.Zhang, B.Moore, Y.Kokhreidze, J.Pedret-Dunn, A.Paz-Ares, L.Bunn, P. A.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/24579enRESILIENT part 1: Pharmacokinetics of second-line (2L) liposomal irinotecan in patients with small cell lung cancer (SCLC)conference outputopen access10.1016/j.annonc.2020.08.15541569-8041http://www.annalsofoncology.org/article/S0923753420415509/pdf573469102377